These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9049232)

  • 41. [Antiviral therapy in chronic hepatitis B].
    Müller R
    Med Klin (Munich); 1987 May; 82(11):414-9. PubMed ID: 3600544
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of diabetes and cholelithiasis on the course and consequences of acute viral hepatitis type B].
    Janas-Skulina U; Kowalski P; Lukaszuk M; Garlicki A; Skulina D
    Folia Med Cracov; 1996; 37(3-4):67-70. PubMed ID: 9312536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 44. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R; Lada O; Marcellin P
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract]   [Full Text] [Related]  

  • 45. Current treatment and future directions in the management of chronic hepatitis B viral infection.
    Gish RG
    Clin Liver Dis; 2005 Nov; 9(4):541-65, v. PubMed ID: 16207563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis].
    Levitan BN; Astakhin AV; Chishieva EM; Afanas'ev SS
    Voen Med Zh; 2004 Feb; 325(2):60-6, 96. PubMed ID: 15101297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
    Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
    Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?
    Johnson PJ; Williams R
    Hepatology; 1991 Dec; 14(6):1293-5. PubMed ID: 1959882
    [No Abstract]   [Full Text] [Related]  

  • 52. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 53. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.
    Le Calvez S; Thabut D; Messous D; Munteanu M; Ratziu V; Imbert-Bismut F; Poynard T
    Hepatology; 2004 Mar; 39(3):862-3; author reply 863. PubMed ID: 14999708
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunomodulator therapy in chronic viral hepatitis].
    Stanciu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic active hepatitis: a 30-year journey with a famous monograph.
    Mackay IR
    Postgrad Med J; 1983; 59 Suppl 4():73-7. PubMed ID: 6647220
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chronic hepatitis B: to treat or not to treat?].
    Fernández JL; Morgante P; Viola LA
    Acta Gastroenterol Latinoam; 1989; 19(1):53-6. PubMed ID: 2481375
    [No Abstract]   [Full Text] [Related]  

  • 57. Progress in the development and use of antiviral drugs and interferon. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1987; 754():1-28. PubMed ID: 2444034
    [No Abstract]   [Full Text] [Related]  

  • 58. [Enzymes of the peripheral blood leukocytes in chronic hepatitis and liver cirrhosis].
    Volkova AA; Moiseeva GL; Shakhova NB; Shabunina EI
    Pediatriia; 1982 Oct; (10):31-3. PubMed ID: 7177743
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic hepatitis.
    Koretz RL
    Am Fam Physician; 1989 Jun; 39(6):197-202. PubMed ID: 2658518
    [No Abstract]   [Full Text] [Related]  

  • 60. Leptin response in patients undergoing interferon therapy.
    Enjoji M; Nakamuta M; Iwao M; Sugimoto R; Kotoh K; Nawata H; Sakai H
    J Clin Gastroenterol; 2002 Mar; 34(3):287-8. PubMed ID: 11873119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.